98.41
price up icon1.98%   1.91
after-market アフターアワーズ: 98.41
loading
前日終値:
$96.50
開ける:
$94.85
24時間の取引高:
2.20M
Relative Volume:
1.33
時価総額:
$7.51B
収益:
$8.10B
当期純損益:
$599.48M
株価収益率:
13.30
EPS:
7.3969
ネットキャッシュフロー:
$971.50M
1週間 パフォーマンス:
+22.89%
1か月 パフォーマンス:
-46.11%
6か月 パフォーマンス:
-45.22%
1年 パフォーマンス:
-48.56%
1日の値動き範囲:
Value
$92.59
$99.52
1週間の範囲:
Value
$81.31
$99.52
52週間の値動き範囲:
Value
$66.57
$211.00

Icon Plc Stock (ICLR) Company Profile

Name
名前
Icon Plc
Name
セクター
Healthcare (1110)
Name
電話
-
Name
住所
-
Name
職員
39,800
Name
Twitter
@ICONplc
Name
次回の収益日
2025-10-22
Name
最新のSEC提出書
Name
ICLR's Discussions on Twitter

Compare ICLR vs TMO, DHR, IDXX, A, WAT

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Diagnostics & Research icon
ICLR
Icon Plc
98.41 7.37B 8.10B 599.48M 971.50M 7.3969
Diagnostics & Research icon
TMO
Thermo Fisher Scientific Inc
515.12 192.95B 44.56B 6.73B 6.29B 17.74
Diagnostics & Research icon
DHR
Danaher Corp
211.25 147.43B 24.57B 3.60B 5.25B 5.0475
Diagnostics & Research icon
IDXX
Idexx Laboratories Inc
630.73 50.70B 4.30B 1.06B 1.04B 13.08
Diagnostics & Research icon
A
Agilent Technologies Inc
126.34 35.90B 6.95B 1.30B 1.15B 4.5696
Diagnostics & Research icon
WAT
Waters Corp
328.66 32.13B 3.17B 642.63M 539.81M 10.77

Icon Plc Stock (ICLR) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2026-02-12 ダウングレード BofA Securities Neutral → Underperform
2026-02-12 ダウングレード Leerink Partners Outperform → Market Perform
2026-01-08 ダウングレード Truist Buy → Hold
2025-12-15 ダウングレード BofA Securities Buy → Neutral
2025-11-13 開始されました BMO Capital Markets Market Perform
2025-09-09 ダウングレード Jefferies Buy → Hold
2025-09-03 アップグレード Rothschild & Co Redburn Neutral → Buy
2025-08-21 ダウングレード Citigroup Buy → Neutral
2025-07-24 アップグレード Robert W. Baird Neutral → Outperform
2025-04-29 ダウングレード JP Morgan Overweight → Neutral
2025-04-14 ダウングレード TD Cowen Buy → Hold
2025-04-10 ダウングレード Barclays Overweight → Equal Weight
2025-03-21 ダウングレード Goldman Buy → Neutral
2025-01-07 開始されました RBC Capital Mkts Outperform
2024-10-24 ダウングレード Robert W. Baird Outperform → Neutral
2024-10-14 開始されました Redburn Atlantic Neutral
2024-09-18 開始されました Leerink Partners Outperform
2024-06-06 開始されました Goldman Buy
2023-12-15 開始されました Truist Buy
2023-09-13 開始されました TD Cowen Outperform
2023-01-17 アップグレード Barclays Equal Weight → Overweight
2023-01-13 アップグレード Barclays Equal Weight → Overweight
2022-11-09 アップグレード BofA Securities Neutral → Buy
2022-09-07 開始されました UBS Buy
2022-08-25 開始されました Credit Suisse Neutral
2022-05-24 開始されました Guggenheim Buy
2022-04-25 ダウングレード Wells Fargo Overweight → Equal Weight
2022-04-12 アップグレード Deutsche Bank Hold → Buy
2021-09-27 アップグレード JP Morgan Neutral → Overweight
2021-08-05 再開されました Credit Suisse Outperform
2021-07-23 アップグレード Citigroup Neutral → Buy
2021-07-14 開始されました Citigroup Neutral
2021-04-13 再開されました BofA Securities Neutral
2021-04-01 アップグレード Wells Fargo Equal Weight → Overweight
2021-03-08 アップグレード Robert W. Baird Neutral → Outperform
2021-03-03 開始されました Barclays Equal Weight
2021-03-01 アップグレード UBS Neutral → Buy
2021-02-26 アップグレード Truist Hold → Buy
2020-07-24 ダウングレード BofA Securities Buy → Neutral
2020-04-20 ダウングレード Robert W. Baird Outperform → Neutral
2020-03-26 アップグレード Barclays Equal Weight → Overweight
2020-03-02 開始されました Deutsche Bank Hold
2020-01-27 ダウングレード SunTrust Buy → Hold
2020-01-08 開始されました Wells Fargo Equal Weight
2020-01-07 開始されました Citigroup Neutral
2019-09-23 ダウングレード KeyBanc Capital Markets Overweight → Sector Weight
2019-07-26 アップグレード UBS Sell → Neutral
2019-01-25 アップグレード Mizuho Neutral → Buy
2018-10-26 アップグレード Evercore ISI In-line → Outperform
2018-10-09 開始されました UBS Sell
2018-04-03 ダウングレード Evercore ISI Outperform → In-line
2018-02-15 繰り返されました Mizuho Neutral
2018-01-19 開始されました Evercore ISI Outperform
2017-10-27 繰り返されました Barclays Equal Weight
2017-09-11 開始されました BofA/Merrill Buy
2017-07-31 アップグレード SunTrust Hold → Buy
2017-07-27 繰り返されました Mizuho Neutral
2017-06-29 アップグレード Jefferies Hold → Buy
すべてを表示

Icon Plc (ICLR) 最新ニュース

pulisher
08:19 AM

73,467 Shares in Icon Plc $ICLR Purchased by Muhlenkamp & Co. Inc. - MarketBeat

08:19 AM
pulisher
12:27 PM

TD Cowen upgrades ICON stock on valuation after accounting probe By Investing.com - Investing.com Nigeria

12:27 PM
pulisher
Feb 18, 2026

ICON INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. is - GlobeNewswire

Feb 18, 2026
pulisher
Feb 18, 2026

Icon plc: Accounting Probe Sell-Off Creates Compelling Value Despite Modest EPS Impact - TipRanks

Feb 18, 2026
pulisher
Feb 18, 2026

2026-02-18 | Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against ICON plc (ICLR) and Encourages Investors to Learn More About the Investigation | NDAQ:ICLR | Press Release - Stockhouse

Feb 18, 2026
pulisher
Feb 18, 2026

ICON plc Faces Investigation After Internal Probe Reveals Multi-Year Revenue Overstatement - GuruFocus

Feb 18, 2026
pulisher
Feb 18, 2026

FDA Grants Breakthrough Status To Johnson & Johnson's Cancer Drug For Advanced Head and Neck Cancer - Benzinga

Feb 18, 2026
pulisher
Feb 18, 2026

TD Cowen upgrades ICON stock on valuation after accounting probe - Investing.com

Feb 18, 2026
pulisher
Feb 18, 2026

Icon Plc $ICLR Shares Sold by Eagle Health Investments LP - MarketBeat

Feb 18, 2026
pulisher
Feb 17, 2026

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against ICON plc (ICLR) and Encourages Stockholders to Learn More About the Investigation - ACCESS Newswire

Feb 17, 2026
pulisher
Feb 17, 2026

ICON Faces Investor Lawsuit Investigation - Intellectia AI

Feb 17, 2026
pulisher
Feb 17, 2026

ICON (ICLR) stock slides as Rothschild Redburn cuts rating, extending pressure from accounting probe - Bez Kabli

Feb 17, 2026
pulisher
Feb 17, 2026

Icon PLC headcount plummets 1,800 in a year amid ‘strong cost control’ - MSN

Feb 17, 2026
pulisher
Feb 17, 2026

ICLR ALERT: Securities Fraud Investigation by Block & Leviton Could Allow ICON pcl Investors to Recover Losses - TradingView

Feb 17, 2026
pulisher
Feb 17, 2026

Rothschild downgrades ICON stock on accounting investigation By Investing.com - Investing.com

Feb 17, 2026
pulisher
Feb 16, 2026

ICON plc (ICLR) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire

Feb 16, 2026
pulisher
Feb 16, 2026

ICON plc (ICLR) Stock Analysis: Unveiling an 87.74% Potential Upside in Healthcare Diagnostics - DirectorsTalk Interviews

Feb 16, 2026
pulisher
Feb 15, 2026

Clinical Research Provider Icon Stock Crashes On Accounting Probe - AOL.com

Feb 15, 2026
pulisher
Feb 15, 2026

ICON (ICLR) Is Down 38.2% After Internal Revenue Probe And Pulled 2025 OutlookWhat's Changed - simplywall.st

Feb 15, 2026
pulisher
Feb 14, 2026

Market briefs: ECB extends interest rate pause and Birkenstock misses estimate - Business Post

Feb 14, 2026
pulisher
Feb 14, 2026

ICON Public Limited Company (ICLR) Delays Earnings Amid Internal Investigation - Finviz

Feb 14, 2026
pulisher
Feb 14, 2026

Icon’s Price Target Revisions Amid Strategic Expansions and New Partnerships - timothysykes.com

Feb 14, 2026
pulisher
Feb 14, 2026

US law firms circle Icon PLC after revelations of accounting probe send shares plunging - The Irish Independent

Feb 14, 2026
pulisher
Feb 14, 2026

ICON PLC (ICON) soars 16% as analyst issues 'hold', $93 PT despite accounting concerns - MSN

Feb 14, 2026
pulisher
Feb 13, 2026

ICON PLC (ICON) Soars 16% as Analyst Issues 'Hold', $93 PT Despite Accounting Concerns - Finviz

Feb 13, 2026
pulisher
Feb 13, 2026

ICON PLC (ICON) Soars 16% as Analyst Issues ‘Hold’, $93 PT Despite Accounting Concerns - Insider Monkey

Feb 13, 2026
pulisher
Feb 13, 2026

ICON plc (ICLR) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade

Feb 13, 2026
pulisher
Feb 13, 2026

ICON (ICLR) stock rebounds after accounting probe shock — what investors watch next - Bez Kabli

Feb 13, 2026
pulisher
Feb 13, 2026

ICON plc Expands Oncology Research, Sets New Price Target - StocksToTrade

Feb 13, 2026
pulisher
Feb 13, 2026

Icon Strategy Expands with New Partnership to Bolster Oncology Research - timothysykes.com

Feb 13, 2026
pulisher
Feb 13, 2026

ICON Expands Oncology Research Capabilities Amidst Positive Stock Reevaluation - StocksToTrade

Feb 13, 2026
pulisher
Feb 13, 2026

ICON plc Expands Clinical Trial Capabilities through Strategic Partnership - timothysykes.com

Feb 13, 2026
pulisher
Feb 13, 2026

Icon Partners with Brian Moran for Key Oncology Expansion - StocksToTrade

Feb 13, 2026
pulisher
Feb 13, 2026

ICON plc Expands Oncology Network, Stock Assessment and Market Analysis - timothysykes.com

Feb 13, 2026
pulisher
Feb 13, 2026

ICON plc Expands Oncology Research, Price Target Upgraded - StocksToTrade

Feb 13, 2026
pulisher
Feb 13, 2026

ICON plc (ICLR) Shares Crater Amid Delayed Financial Report, Investigation Into Revenue Recognition IssuesHagens Berman - The Malaysian Reserve

Feb 13, 2026
pulisher
Feb 13, 2026

ICON (ICLR) Is Down 44.9% After Probing Revenue Recognition And Control WeaknessesWhat's Changed - Yahoo Finance

Feb 13, 2026
pulisher
Feb 13, 2026

Truist Financial Maintains Icon PLC(ICLR.US) With Hold Rating - 富途牛牛

Feb 13, 2026
pulisher
Feb 13, 2026

ICON plc (ICLR) Shares Crater Amid Delayed Financial Report, Inv - GuruFocus

Feb 13, 2026
pulisher
Feb 13, 2026

ICON (ICLR) stock steadies premarket after 40% crash on accounting probe — what’s next - Bez Kabli

Feb 13, 2026
pulisher
Feb 13, 2026

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against ICON plc (ICLR) And Encourages Investors to Reach Out - ACCESS Newswire

Feb 13, 2026
pulisher
Feb 13, 2026

Icon PLC stock hits 52-week low at $79.49 By Investing.com - Investing.com Australia

Feb 13, 2026
pulisher
Feb 13, 2026

Here's How Much $100 Invested In Icon 20 Years Ago Would Be Worth Today - Sahm

Feb 13, 2026
pulisher
Feb 13, 2026

ICON stock plummets after accounting investigation delays earnings By Investing.com - Investing.com

Feb 13, 2026
pulisher
Feb 13, 2026

ICON stock rating suspended by Evercore amid accounting investigation By Investing.com - Investing.com Canada

Feb 13, 2026
pulisher
Feb 12, 2026

ICON stock rating downgraded by BofA Securities amid accounting concerns - Investing.com UK

Feb 12, 2026
pulisher
Feb 12, 2026

Ademi LLP Investigates Claims of Securities Fraud against ICON plc - The Malaysian Reserve

Feb 12, 2026
pulisher
Feb 12, 2026

ICON Public Limited Company Under Investigation for Securities Law Violations - Intellectia AI

Feb 12, 2026
pulisher
Feb 12, 2026

ICON plc Shares Plunge 49% Amid Revenue Recognition Investigation - Intellectia AI

Feb 12, 2026
pulisher
Feb 12, 2026

ICON plc (ICLR) Shares Crater Amid Delayed Financial - GlobeNewswire

Feb 12, 2026
pulisher
Feb 12, 2026

Medtech Plummets 40% On Profit-Threatening Investigation - Investor's Business Daily

Feb 12, 2026

Icon Plc (ICLR) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
diagnostics_research DGX
$202.44
price down icon 0.95%
diagnostics_research LH
$282.48
price up icon 1.33%
diagnostics_research MTD
$1,376.53
price up icon 0.07%
diagnostics_research IQV
$169.36
price down icon 0.99%
$216.36
price up icon 0.39%
diagnostics_research WAT
$328.66
price up icon 0.35%
大文字化:     |  ボリューム (24 時間):